市场调查报告书
商品编码
1494852
2030 年医疗机器人系统市场预测:按产品类型、类型、组件、部署类型、服务、应用程式、最终用户和地区进行的全球分析Medical Robotic System Market Forecasts to 2030 - Global Analysis By Product Type, Type, Component, Deployment Type, Service, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球医疗机器人系统市场规模将达到 299.7 亿美元,预计到 2030 年将达到 846.8 亿美元,在预测期内复合年增长率为 18.9%。
医疗机器人系统是技术和医疗保健的革命性融合,将彻底改变手术的执行和治疗方式。这些先进的设备使外科医生能够比人类更精确、更灵活地执行复杂的手术,同时降低患者的风险。此外,凭藉先进的感测器、成像技术和人工智慧演算法,医疗机器人能够以无与伦比的精度导航精密的解剖结构。
根据国际机器人联合会 (IFR) 的数据,医疗机器人的采用正在迅速扩大,预计到年终,全球将安装 17,000 台手术机器人。
对微创手术的需求不断增长
疼痛更少、住院时间更短、恢復时间更短、切口更小、疤痕更少,这些只是微创手术相对于开放性手术的一些优点。对医疗机器人系统的需求正在增加,因为它们允许外科医生以更好的控制和精确度来执行这些手术。此外,医疗保健相关人员正在投资越来越多的机器人辅助手术系统,以满足患者对微创手术的需求。
初始价格高
医疗机器人系统的高昂初始成本是普及的主要障碍之一。对于医疗机构来说,除了相关的培训和维护成本之外,购买机器人手术系统的初始成本可能会很高。由于需要专门的基础设施和定期软体更新,成本负担进一步增加。此外,这些高昂的成本是投资机器人技术的主要障碍,特别是对于小型医疗保健提供者和在资源有限的环境中工作的人来说。
技术创新与科学进步
由于机器人技术的不断进步,例如更小、更灵活的机器人平台的开发、改进的显像模式以及基于人工智慧的手术支持,医疗机器人系统市场具有很大的潜力。科技公司、医疗机构和研究小组之间的合作将使发现新用途和改进已在使用的机器人平台变得更容易。此外,由于研发 (R&D)计划的投资,例如改进手术方法、提高医疗机器人的功能以及探索新的治疗领域,医疗机器人系统市场正在不断增长。
市场饱和与竞争
随着越来越多的公司进入市场并提供类似的技术,医疗机器人系统市场的竞争变得越来越激烈。因此,市场有可能饱和,医疗机器人系统的供应超过需求。价格战、利润空间缩小以及供应商和製造商的盈利下降都是激烈竞争的后果。此外,医疗机器人系统在某些专业领域的主导地位正受到替代手术技术和技术普及的威胁,例如影像导引介入和腹腔镜手术。
医疗机器人系统市场受到了 COVID-19 爆发的多方面影响。在大流行的早期阶段,由于製造、供应链物流和选择性外科手术的中断,市场成长暂时放缓。然而,由于社交距离的需要以及对感染控制的重视,机器人辅助手术的采用正在加速。医疗机构越来越多地使用机器人系统来提高手术精度、降低病毒感染风险并节省个人防护工具。
软体平台产业预计将在预测期内成为最大的产业
医疗机器人系统市场通常由软体平台领域主导。这是因为资料处理、机器人运动控制和硬体到硬体的通讯都是由医疗机器人系统核心的软体平台实现的。这些平台透过使用尖端演算法、人工智慧 (AI) 和机器学习功能来实现精确的手术导引、规划和执行。此外,软体平台对于提高工作流程效率、确保机器人辅助手术期间的病患安全以及增强使用者体验至关重要。
云端基础的细分市场预计在预测期内复合年增长率最高
在医疗机器人系统市场中,云端基础的细分市场通常具有最高的复合年增长率。云端基础的解决方案因其许多优势(包括扩充性、灵活性和可访问性)而对医疗设备製造商和医疗保健提供者越来越有吸引力。此外,云端基础的医疗机器人系统透过实现即时资料共用、远端监控和协作工作流程来提高生产力、连接性和患者照护服务。
北美占据医疗机器人系统市场的最大份额。这一优势归因于复杂的医疗基础设施、高昂的医疗成本、有利的报销实践以及有利于医疗机器人系统采用的强有力的法规环境等因素。此外,该地区拥有由医疗保健提供者、研究机构和技术公司组成的强大生态系统,可促进创新和市场扩张。美国由于机器人辅助手术在妇科、一般外科、泌尿系统等各专科的广泛使用,占据了很大的市场。
亚太地区的医疗机器人系统市场的复合年增长率通常最高。对先进治疗方案的认识不断提高、可支配收入不断增加、医疗技术投资以及医疗基础设施快速发展是推动这一增长的因素。由于慢性病增加、人口老化以及微创手术的转变,包括中国、日本、韩国和印度在内的亚太地区对医疗机器人系统的需求正在迅速增长。此外,鼓励性的政府计划、有益的立法以及外国製造商和当地医疗保健提供者之间的合作伙伴关係都有助于该地区的市场扩张。
According to Stratistics MRC, the Global Medical Robotic System Market is accounted for $29.97 billion in 2024 and is expected to reach $84.68 billion by 2030 growing at a CAGR of 18.9% during the forecast period. Medical robotic systems are a revolutionary fusion of technology and healthcare that will completely change how procedures are carried out and treatments are given. These advanced devices are made to help surgeons perform complex procedures with greater accuracy and dexterity than is humanly possible, all while lowering patient risks. Moreover, medical robots can navigate delicate anatomical structures with unparalleled accuracy thanks to their advanced sensors, imaging technologies, and AI algorithms.
According to the International Federation of Robotics (IFR), the adoption of medical robotics is rapidly expanding, with an estimated 17,000 units of surgical robots installed worldwide by the end of 2020.
Growing requirement for less invasive surgery
Reduction in pain, shorter hospital stays, quicker recovery periods, and smaller incisions that leave fewer scars are just a few advantages that minimally invasive surgeries have over open procedures. There is a growing demand for medical robotic systems because they allow surgeons to perform these procedures with greater control and precision. Additionally, medical professionals are investing in robotically assisted surgical systems in response to patient demand for less invasive procedures, which is on the rise.
High starting prices
The high initial costs of medical robotic systems are one of the main obstacles preventing their widespread adoption. For healthcare facilities, the initial cost of purchasing robotic surgical systems, in addition to related training and maintenance costs can be significant. The expense burden is further increased by the requirement for specialized infrastructure and regular software updates. Furthermore, these exorbitant expenses are a major deterrent to investing in robotic technologies, especially for smaller healthcare providers or those working in resource-constrained environments.
Innovations in technology and scientific progress
The medical robotic system market has a lot of potential due to ongoing advancements in robotic technology, which include the creation of smaller, more nimble robotic platforms, improved imaging modalities, and AI-driven surgical assistance. Technology companies, healthcare facilities, and research groups working together make it easier to discover new uses for robotic platforms already in use and to improve them. Moreover, the market for medical robotic systems is also evolving as a result of investments in research and development (R&D) projects that enhance surgical methods, increase the capabilities of medical robots, and investigate novel therapeutic areas.
Market saturation and competition
The market for medical robotic systems is getting more and more competitive as more businesses enter the market and offer comparable technologies. The possibility of market saturation, in which the supply of medical robotic systems exceeds the demand, arises as a consequence. Price wars, shrinking profit margins, and decreased profitability for suppliers and manufacturers are all consequences of intense competition. Additionally, the dominance of medical robotic systems in some specialties is threatened by the spread of alternative surgical techniques and technologies like image-guided interventions and laparoscopic surgery.
The market for medical robotic systems has been affected by the COVID-19 pandemic in a number of ways. A temporary slowdown in market growth was caused by the initial phase of the pandemic, which caused disruptions in manufacturing, supply chain logistics, and elective surgical procedures. However, the adoption of robotic-assisted surgeries has accelerated due to the need for social distancing and the subsequent emphasis on infection control measures. Healthcare facilities have been using robotic systems more and more to improve surgical precision, reduce the risk of viral transmission, and preserve personal protective equipment.
The Software Platform segment is expected to be the largest during the forecast period
The medical robotic system market is usually dominated by the software platform segment. This is so that data processing, robotic movement control, and hardware-to-hardware communication are all made possible by the software platform, which forms the core of medical robotic systems. These platforms enable precise surgical navigation, planning, and execution through the use of cutting-edge algorithms, artificial intelligence (AI), and machine learning capabilities. Furthermore, software platforms are essential for improving workflow efficiency, guaranteeing patient safety during robotically assisted procedures, and improving the user experience.
The Cloud Based segment is expected to have the highest CAGR during the forecast period
In the medical robotic system market, the cloud-based segment usually has the highest CAGR. Cloud-based solutions are becoming more and more appealing to medical device manufacturers and healthcare providers due to their many benefits, which include scalability, flexibility, and accessibility. Moreover, cloud-based medical robotic systems improve productivity, connectivity, and patient care delivery by enabling real-time data sharing, remote monitoring, and collaborative workflows.
In the medical robotic system market, North America usually holds the largest share. This dominance is ascribed to elements like the existence of a sophisticated healthcare infrastructure, high healthcare costs, advantageous reimbursement practices, and a strong regulatory environment that fosters the uptake of medical robotic systems. Additionally, the area also gains from a robust ecosystem of healthcare providers, research institutes, and technology companies that foster innovation and market expansion. Due to the extensive use of robotic-assisted surgeries in a variety of specialties, including gynecology, general surgery, and urology, the United States holds a sizable share of the market.
In the medical robotic system market, Asia-Pacific usually has the highest CAGR. A growing awareness of advanced treatment options, rising disposable incomes, investments in medical technology, and a quickly growing healthcare infrastructure are some of the factors driving this growth. The Asia-Pacific region, which includes China, Japan, South Korea, and India, is seeing a sharp increase in the demand for medical robotic systems due to the growing prevalence of chronic illnesses, an aging population, and a move toward minimally invasive surgical procedures. Moreover, encouraging government programs, helpful laws, and alliances between foreign producers and regional healthcare providers all contribute to the market's expansion in the area.
Key players in the market
Some of the key players in Medical Robotic System market include Hitachi Medical Systems, Auris Surgical Robotics Inc. (Hansen Medical Inc.), Mako Surgical Corp., Omnicell Technologies, Medtronic, Renishaw Plc, Accuray Incorporated, Intuitive Surgical Inc., Siemens Healthineers AG, Mazor Robotics Ltd, iRobot Corporation, Stryker Corporation, Titan Medical Inc., Varian Medical Systems and Smith & Nephew PLC.
In May 2024, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions that help improve patient outcomes worldwide. As the two companies sign a new agreement, we look back on their achievements, and their continuing impact on diagnostics and beyond.
In December 2023, Medtronic plc, a global leader in healthcare technology, announces that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals.
In August 2023, Siemens Healthineers is teaming up with Catholic non-profit health care system SSM Health in a new 10-year strategic partnership aimed at advancing access to high-quality care and training of health care workers in the Midwest region of the US.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.